Clinical Trials Logo

Filter by:
NCT ID: NCT00297895 Completed - Melanoma Clinical Trials

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Start date: September 30, 2004
Phase: N/A
Study type: Interventional

Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed for 10 years.

NCT ID: NCT00297609 Completed - Critical Care Clinical Trials

Prevention of Errors in Resuscitation Medications Orders by Means of a Computerized Physician Order Entry

Start date: January 2002
Phase: N/A
Study type: Observational

Computerized physician order entry with clinical decision support system CPOE+CDSS)completely eliminated errors in filling in the resuscitation medications order forms and significantly reduced time to completing the forms in a pediatric critical care department (PCCD).

NCT ID: NCT00297570 Recruiting - Clinical trials for Leukemia, Myeloid, Philadelphia-Positive

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The study is controlled and randomized in Philadelphia-positive chronic myeloid leukemia (Ph+ CML) patients with complete cytogenetic response after more than one year of imatinib therapy. The aim is to explore a possible benefit in the addition of peg-interferon (Peg-IFN) to imatinib, in terms of the rate of achievement, molecular remission, and response duration.

NCT ID: NCT00297544 Recruiting - Impotence Clinical Trials

Effect of Sildenafil on Endothelial Function

Start date: October 2005
Phase: N/A
Study type: Interventional

We are investigating the chronic effect of daily assumption of Viagra on the blood vessels function in patients with impotence. The study will include 2 groups: 1- patients with multiple risk factors, e.g. hypertension 2- patients with no cardiovascular risk factors

NCT ID: NCT00297414 Completed - Clinical trials for Mild Cognitive Impairment

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Start date: June 2004
Phase: Phase 3
Study type: Observational

The purpose of the study is to collect data of patients who were randomized (assignment of study medication by chance) and treated in 3 previous studies of galantamine (CR003145, CR002014 and CR005947) for the treatment of mild cognitive impairment (isolated memory impairment). This data were not recorded during the course of these 3 previous studies.

NCT ID: NCT00297232 Terminated - Clinical trials for Relapsing-Remitting Multiple Sclerosis

Natalizumab (Tysabri) Re-Initiation of Dosing

STRATA
Start date: March 2006
Phase: Phase 3
Study type: Interventional

The primary objectives for the initial treatment period of this study are to further evaluate the safety of natalizumab monotherapy by evaluating the risk of hypersensitivity reactions and immunogenicity following re-exposure to natalizumab and confirming the safety of switching from interferon (IFN), glatiramer acetate, or other multiple sclerosis (MS) therapies to natalizumab. The primary objective for the long-term treatment period of this study is to evaluate the long-term impact of natalizumab monotherapy on the progression of disability measured by Expanded Disability Status Scale (EDSS) changes over time.

NCT ID: NCT00296751 Completed - Labor Pain Clinical Trials

Epidural Analgesia Versus IV Meperidine for Labor Pain Control

Start date: March 2006
Phase: N/A
Study type: Interventional

60 female that care for pain control during second stage of delivery, will choose between epidural or systemic analgesia. Continuous ECG (3 lead)monitoring will be recorded during the second stage for 10 minutes. 30 minutes after administration of either pain relief, a second recording of maternal ECG will take place for 10 minutes.

NCT ID: NCT00296738 Completed - Cardiac Diseases Clinical Trials

123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation

Start date: May 2007
Phase: Phase 0
Study type: Observational

Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF

NCT ID: NCT00296348 Completed - Clinical trials for Kidney Transplantation

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation

TWIST
Start date: November 2005
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to investigate the impact of early corticosteroid withdrawal in paediatric renal transplant patients on growth expressed as change in height standard deviation score (SDS) from baseline to end of study as the primary endpoint. The expected advantages are reduced growth suppression, lower incidence of arterial hypertension and post transplant diabetes mellitus (PTDM) and improved lipid metabolism, expressed by lower serum lipid values.

NCT ID: NCT00295399 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Telerehabilitation for the Hand and Arm After Stroke and Traumatic Brain Injury

Start date: n/a
Phase: N/A
Study type: Interventional

The goal of this project is to develop a low-cost, user-friendly, portable telerehabilitation system for physical therapy of the upper limb after stroke or traumatic brain injury. The system is based on the use of a commercially available force feedback joystick and will work with an ordinary home PC and a standard high-speed internet connection. Using the joystick, the patient will perform exercises designed to aid in recovering motor function of the hand and arm. The joystick will be programmed to either assist or resist the patient's movements. The system will include sophisticated analysis of patient status and progress to provide the therapist and physician with detailed information. In the first phase of the study, we will develop the system in cooperation with the physical therapy staff and other rehabilitation specialists. The investigators will examine the usability, comfort, safety and therapeutic benefit of the system. In the second phase of the study, the investigators will employ the system in patients' homes, using the internet to connect to rehabilitation specialists in the clinic. The study hypothesis is that it is possible to adapt commercially available, low cost gaming equipment such as force feedback joysticks to provide therapy for patients in their own homes, and that patients will be able to work with this system and will find it enjoyable and helpful for recovering motor function.